atai Life Sciences N.V.
Latest round
- Series D
Last raised
- Mar 2021
Total raised
- $328M
Investors
- 17
About atai Life Sciences N.V.
V. operates as a biopharmaceutical company aiming to transform the treatment of mental health disorders. The company was co-founded by Founder Christian Angermayer, CEO Florian Brand, CSO Srinivas Rao, and Lars Christian Wilde. Christian Angermayer. The company filed its IPO Filing in February 2021. The company operates as a biopharmaceutical company that develops disease-modifying mental health treatments by researching both psychedelic and non-psychedelic compounds. It is dedicated to acquiring, incubating, and efficiently developing innovative therapeutics to treat depression, anxiety, addiction, and other mental health disorders. The company plans to expand and develop its drug candidate pipeline and enabling technologies, continue its current clinical developments, and hire teams in order to continue delivering key milestones. The company also plans to be listed on the Nasdaq under the symbol ATAI.
Who invested in atai Life Sciences N.V.
17 investors across 4 rounds
See all investors in atai Life Sciences N.V.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about atai Life Sciences N.V.
Who invested in atai Life Sciences N.V.?
atai Life Sciences N.V. has 17 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has atai Life Sciences N.V. raised?
atai Life Sciences N.V. has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did atai Life Sciences N.V. last raise money?
atai Life Sciences N.V.'s most recent round on record is a Series D, in Mar 2021.
What does atai Life Sciences N.V. do?
atai Life Sciences N.V. is a biotechnology company.
Where is atai Life Sciences N.V. headquartered?
atai Life Sciences N.V. is headquartered in Berlin, Germany.
Which VCs invest in companies like atai Life Sciences N.V.?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at atai Life Sciences N.V.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like atai Life Sciences N.V.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.